herp
simplex
viru
one
common
sexual
transmit
infect
sti
genit
skin
mucosa
primari
infect
infect
genit
epitheli
cell
transport
via
sensori
nerv
sacral
root
ganglion
lifelong
latenc
establish
intermitt
genit
shed
immunocompet
person
frequent
without
symptom
situ
analysi
skin
biopsi
lesion
reveal
cellular
infiltr
consist
inflammatori
cell
persist
month
heal
even
daili
antivir
therapi
genit
skin
lesion
activ
mucos
immun
respons
time
local
reactiv
increas
risk
sexual
transmiss
viru
well
risk
acquir
genit
infect
present
studi
straightforward
demonstr
mrna
level
sever
marker
inflamm
epitheli
barrier
integr
foreskin
herp
simplex
viru
type
seroposit
seroneg
young
men
undergo
elect
circumcis
measur
mrna
transcript
tissu
sampl
reveal
cell
sourc
marker
neither
allow
quantif
marker
protein
level
assess
tissu
sampl
time
circumcis
studi
crosssect
data
avail
regard
histori
recurr
local
lesion
studi
defin
whether
lower
mrna
level
indic
infect
infect
caus
reduc
mrna
level
includ
hiv
although
daili
antivir
therapi
reduc
viral
replic
visibl
lesion
persist
mucos
inflamm
human
skin
sampl
includ
upregul
hiv
coreceptor
dcsign
may
partli
explain
inabl
therapi
reduc
acquisit
hiv
disrupt
male
foreskin
epitheli
barrier
import
risk
factor
viral
entri
sexual
intercours
foreskin
mucosa
thu
highli
relev
site
investig
viral
transmiss
especi
context
repres
studi
popul
young
men
live
hiv
endem
region
male
foreskin
consist
keratinis
stratifi
epitheli
layer
epitheli
cell
express
number
tight
junction
adhes
protein
togeth
form
function
barrier
invad
pathogen
barrier
function
easili
disrupt
mucos
inflamm
human
skin
tight
junction
complex
three
major
transmembran
protein
identifi
claudin
occludin
junction
adhes
molecul
ecadherin
major
adhes
protein
express
basal
side
tight
junction
protein
complex
among
protein
famili
occludin
ecadherin
identifi
foreskin
keratinocyt
foreskin
tissu
pathogen
often
use
specif
epitheli
intercellular
junction
protein
mean
entri
human
skin
hsv
infect
keratinocyt
complex
interact
involv
protein
reduct
express
anoth
junction
protein
associ
enhanc
suscept
infect
patient
atop
dermat
hiv
sexual
transmit
male
femal
genit
tract
mucosa
import
site
viral
entri
hiv
cross
genit
epitheli
barrier
viru
mainli
replic
submucos
cell
infect
spread
region
lymphnod
system
circul
thu
inflammatori
milieu
defin
increas
express
specif
chemokin
proinflammatori
molecul
result
recruit
cell
increas
risk
system
hiv
infect
hypothes
seroposit
associ
genit
mucos
inflamm
disrupt
epitheli
barrier
even
asymptomat
individu
may
theoret
contribut
higher
suscept
hiv
infect
observ
seroposit
individu
foreskin
tissu
obtain
randomis
placebocontrol
clinic
trial
conduct
kisumu
kenya
univers
nairobi
illinoi
manitoba
collabor
research
project
men
age
year
recruit
unblind
trial
two
arm
circumcis
arm
delay
circumcis
control
arm
examin
whether
male
circumcis
reduc
hiv
incid
present
studi
sampl
randomli
select
circumcis
stratifi
serolog
statu
equal
number
specimen
randomli
select
stratum
match
age
year
std
screen
includ
histori
discharg
previous
diagnos
sexual
transmit
infect
sti
clinic
examin
week
time
circumcis
well
laboratori
analysi
neisseria
gonorrhoea
chlamydia
trachomati
trichomona
vaginali
haemophilu
ducreyi
chancroid
treponema
pallidum
syphili
serum
specimen
test
antibodi
kalon
igg
elisa
kalon
biolog
limit
aldershot
uk
use
manufactur
recommend
cutoff
foreskin
tissu
process
immedi
laboratori
studi
clinic
make
two
horizont
cut
mm
apart
approxim
cm
distal
end
intact
foreskin
orient
frenulum
centr
inner
outer
mucosa
specif
mark
time
process
tissu
biopsi
immedi
embed
optim
cut
temperatur
oct
snap
frozen
follow
surgeri
dissect
subsequ
store
time
analysi
oct
discard
biopsi
disrupt
lysi
buffer
use
mechan
rotor
rna
extract
accord
manufactur
protocol
rneasi
qiagen
hilden
germani
convert
equal
dilut
cdna
singl
revers
transcriptas
reaction
use
superscript
revers
transcriptas
invitrogen
carlsbad
california
usa
random
hexanucleotid
primer
roch
basel
switzerland
dna
store
amplif
cdna
hladr
langerin
dcsign
mannos
receptor
iga
ecadherin
occludin
perform
use
abi
prism
sequenc
detect
system
commerci
fam
dyelabel
taqman
mgb
probe
primer
appli
biosystem
foster
citi
california
usa
sampl
control
run
duplic
rel
quantiti
target
cdna
comput
use
compar
threshold
ct
method
ct
valu
target
cdna
normalis
ubiquitin
c
ubc
use
normalis
express
ratio
thu
amount
mrna
express
describ
rel
quantiti
ubc
rq
immunofluoresc
stain
perform
thick
section
cryopreserv
foreskin
biopsi
section
fix
ethanol
aceton
thereaft
tissu
section
block
phosphatebuff
salin
pb
saponin
bsac
aurion
wageningen
netherland
follow
overnight
incub
primari
antibodi
select
mous
igg
monoclon
antibodi
detect
human
ecadherin
kindli
provid
dr
kj
green
dr
hope
northwestern
univers
feinberg
school
medicin
chicago
illinoi
usa
polyclon
invitrogen
life
technolog
europ
bv
stockholm
sweden
mouseantioccludin
clone
invitrogen
polyclon
abcam
thereaft
tissu
section
wash
block
pb
contain
saponin
bsac
normal
donkey
serum
min
room
temperatur
follow
h
incub
either
alexa
conjug
donkey
antimous
igg
antibodi
alexa
donkeyantirabbit
igg
antibodi
invitrogenmolecular
probe
section
wash
nuclei
stain
dapi
dihydrochlorid
invitrogen
min
tissu
section
mount
slowfad
gold
antifad
reagent
molecular
probe
neg
control
consist
incub
presenc
secondari
antibodi
characterist
seroneg
seroposit
particip
compar
pearson
test
fisher
exact
test
cell
size
less
amount
express
mrna
analys
unpair
twotail
mannwhitney
test
analys
perform
statas
softwar
stata
corp
colleg
station
texa
usa
graphpad
prism
graphpad
softwar
inc
la
jolla
california
usa
foreskin
tissu
obtain
seroneg
seroposit
men
undergo
elect
circumcis
accord
inclus
criteria
men
clinic
laboratori
sign
genit
ulcer
time
circumcis
data
avail
regard
serostatu
time
primari
infect
possibl
recurr
locat
lesion
data
sociodemograph
behaviour
risk
sti
two
studi
group
statist
similar
except
educ
attain
number
sex
partner
higher
seroposit
group
respect
tabl
overal
immun
activ
statu
foreskin
tissu
sampl
assess
mrna
express
panel
molecul
phenotyp
marker
mrna
express
level
cytokin
immunoregulatori
receptor
hladr
well
iga
similar
studi
group
p
likewis
mrna
express
level
phenotyp
cellular
marker
activ
marker
clr
langerin
dcsign
mannos
receptor
differ
significantli
studi
group
p
data
shown
mrna
express
epitheli
junction
molecul
ecadherin
occludin
compar
two
studi
group
seroposit
men
significantli
lower
mrna
express
median
seroneg
men
median
wherea
group
similar
express
level
ecadherin
occludin
respect
figur
mrna
express
also
compar
age
behaviour
risk
signific
differ
seen
data
shown
irregular
distribut
within
foreskin
epitheli
layer
epitheli
localis
assess
foreskin
tissu
immunofluoresc
stain
although
clearli
present
foreskin
epithelium
protein
evenli
locat
area
area
foreskin
surfac
stain
epitheli
layer
wherea
area
thicker
figur
comparison
junction
protein
ecadherin
occludin
also
individu
pattern
express
unevenli
distribut
throughout
epithelium
figur
found
mrna
express
panel
inflammatori
marker
associ
serostatu
assess
male
foreskin
tissu
asymptomat
kenyan
young
men
howev
mrna
express
significantli
lower
sampl
seroposit
seroneg
men
foreskin
tissu
collect
randomis
clinic
trial
circumcis
sampl
stratifi
serostatu
match
age
particip
studi
individu
accord
enrol
criteria
visibl
laboratori
confirm
genit
lesion
prior
sampl
collect
subclin
clinic
inflamm
usual
characteris
increas
express
cytokin
influx
inflammatori
cell
partial
disrupt
epitheli
barrier
defin
downregul
epitheli
junction
protein
paramet
therefor
assess
molecular
level
measur
mrna
express
panel
immun
marker
immunofluoresc
stain
epitheli
junction
protein
show
localis
protein
ecadherin
occludin
foreskin
tissu
sampl
distribut
entir
epitheli
surfac
sampl
irregular
area
thick
surfac
interspers
thin
posit
stain
cell
layer
well
differ
stain
intens
therefor
possibl
standardis
quantif
protein
level
henc
reli
mrna
express
read
correl
mrna
protein
express
specif
epitheli
marker
also
evalu
studi
viru
infect
human
epitheli
cell
show
compar
express
level
epitheli
junction
protein
highli
dynam
paracellular
permeabl
affect
variou
viru
infect
includ
rhinoviru
acut
respiratori
coronaviru
influenza
west
nile
ebola
virus
case
west
nile
viru
viral
capsid
degrad
claudin
protein
infect
epitheli
endotheli
cell
caus
endocytosi
subset
tight
junction
protein
includ
also
involv
dengu
viru
hepat
c
viru
entri
genet
variant
may
alter
suscept
hcv
infect
contribut
atop
dermat
sinc
reduct
express
enhanc
suscept
infect
atop
dermat
implic
tight
junction
critic
barrier
structur
import
contain
spread
epiderm
infect
thu
lower
mrna
express
seen
seroposit
group
present
studi
reminisc
reduct
enhanc
suscept
describ
alter
express
level
may
also
affect
suscept
genit
infect
sinc
repres
fragil
epitheli
barrier
statu
howev
could
assess
present
studi
sinc
men
symptomat
laboratoryconfirm
genit
infect
elig
circumcis
seroposit
studi
like
repres
previou
lesion
locat
foreskin
major
particip
even
though
could
detect
persist
inflamm
foreskin
tissu
defin
mrna
express
number
immun
marker
exclud
effect
addit
inflammatori
cytokin
interferon
transform
growth
neither
result
exclud
associ
longstand
effect
immun
respons
previous
describ
futur
longitudin
studi
plan
evalu
whether
persist
downregul
follow
lesion
present
crosssect
studi
format
allow
assess
tempor
role
reduct
mrna
express
studi
particip
may
also
prior
genet
induc
defect
express
increas
suscept
men
present
studi
sexual
activ
live
hiv
endem
geograph
area
thu
demonstr
serostatu
associ
gener
mucos
inflamm
foreskin
tissu
level
associ
seroposit
lower
mrna
express
warrant
studi
sinc
specif
defect
genit
mucos
barrier
highli
vulner
relev
popul
could
signific
less
robust
genit
epitheli
barrier
seroposit
men
would
pathogen
factor
facilit
entranc
sti
includ
hiv
topic
compound
strengthen
epitheli
layer
interest
prophylact
approach
lower
sexual
transmiss
acquisit
genit
infect
